Literature DB >> 17069620

The effect of ingestion of milk supplemented with salivaricin A-producing Streptococcus salivarius on the bacteriocin-like inhibitory activity of streptococcal populations on the tongue.

Karen P Dierksen1, Chris J Moore, Megan Inglis, Philip A Wescombe, John R Tagg.   

Abstract

The colonization efficacies of salivaricin A (SalA)-producing Streptococcus salivarius strains 20P3 and 5 were compared when given in milk to 219 children, using either 2-day or 9-day dosing regimens. Colonization levels overall were superior for strain 5, and the 9-day dosing schedule resulted in higher levels of both initial colonization and strain persistence. The indigenous streptococcal tongue populations of 20 (10.9%) of the 189 children in the 2-day trial showed markedly increased SalA-like inhibitory activity following use of the S. salivarius-supplemented milk. All 20 of these children were found to have had relatively small (<5% of total S. salivarius) indigenous tongue populations of SalA-producing S. salivarius, and the relative proportions and/or inhibitory activity of these SalA producers on the childrens' tongues increased following ingestion of the S. salivarius-supplemented milk. Because SalA is known to be strongly inhibitory to Streptococcus pyogenes, an important implication of this study is that the consumption of SalA-producing probiotic S. salivarius could potentially help to effect a sustained increase in SalA-mediated protection against S. pyogenes infection.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17069620     DOI: 10.1111/j.1574-6941.2006.00228.x

Source DB:  PubMed          Journal:  FEMS Microbiol Ecol        ISSN: 0168-6496            Impact factor:   4.194


  14 in total

Review 1.  Streptococcus adherence and colonization.

Authors:  Angela H Nobbs; Richard J Lamont; Howard F Jenkinson
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

Review 2.  Probiotics in human health and disease: from nutribiotics to pharmabiotics.

Authors:  Eun-Sook Lee; Eun-Ji Song; Young-Do Nam; So-Young Lee
Journal:  J Microbiol       Date:  2018-10-24       Impact factor: 3.422

3.  Salivaricin D, a novel intrinsically trypsin-resistant lantibiotic from Streptococcus salivarius 5M6c isolated from a healthy infant.

Authors:  Dagim Jirata Birri; Dag Anders Brede; Ingolf F Nes
Journal:  Appl Environ Microbiol       Date:  2011-11-18       Impact factor: 4.792

4.  Something Old and Something New: An Update on the Amazing Repertoire of Bacteriocins Produced by Streptococcus salivarius.

Authors:  Philip A Wescombe; Nicholas C K Heng; Jeremy P Burton; John R Tagg
Journal:  Probiotics Antimicrob Proteins       Date:  2010-03       Impact factor: 4.609

5.  Streptococcal Bacteriocin-Like Inhibitory Substances: Some Personal Insights into the Bacteriocin-Like Activities Produced by Streptococci Good and Bad.

Authors:  John Robert Tagg
Journal:  Probiotics Antimicrob Proteins       Date:  2009-02-21       Impact factor: 4.609

6.  Preliminary investigations of the colonisation of upper respiratory tract tissues of infants using a paediatric formulation of the oral probiotic Streptococcus salivarius K12.

Authors:  D A Power; J P Burton; C N Chilcott; P J Dawes; J R Tagg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-06-17       Impact factor: 3.267

Review 7.  The dual role of bacteriocins as anti- and probiotics.

Authors:  O Gillor; A Etzion; M A Riley
Journal:  Appl Microbiol Biotechnol       Date:  2008-10-14       Impact factor: 4.813

8.  Prospects for the development of probiotics and prebiotics for oral applications.

Authors:  Deirdre A Devine; Philip D Marsh
Journal:  J Oral Microbiol       Date:  2009-05-01       Impact factor: 5.474

9.  Persistence of the oral probiotic Streptococcus salivarius M18 is dose dependent and megaplasmid transfer can augment their bacteriocin production and adhesion characteristics.

Authors:  Jeremy P Burton; Philip A Wescombe; Jean M Macklaim; Melissa H C Chai; Kyle Macdonald; John D F Hale; John Tagg; Gregor Reid; Gregory B Gloor; Peter A Cadieux
Journal:  PLoS One       Date:  2013-06-13       Impact factor: 3.240

10.  Salivaricin G32, a Homolog of the Prototype Streptococcus pyogenes Nisin-Like Lantibiotic SA-FF22, Produced by the Commensal Species Streptococcus salivarius.

Authors:  Philip A Wescombe; Kristin H Dyet; Karen P Dierksen; Daniel A Power; Ralph W Jack; Jeremy P Burton; Megan A Inglis; Anna L Wescombe; John R Tagg
Journal:  Int J Microbiol       Date:  2012-04-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.